Bcl-2 is transcriptionally regulated by NF-κB and this activity is mediated through a functional NF-κB site identified in the Bcl-2 p2 promoter in PCa cell lines (Catz and Johnson, 2001). The gene discussed is NFKB1; the disease is posterior cortical atrophy.